A randomized, controlled, multicenter phase iii study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) Ann Rheum Dis 2010;69(Suppl3):93

Autor:	DE VITA, Salvatore, Quartuccio, Luca, Masolini, P., Stefania, S., De Marchi, G., Zabotti, A., Mazzaro, C., Lenzi, P. Scaini M., Campanini, M., Scarpato, S., Tavoni, A., Pietrogrande, M., Ferri, C., Mascia, M. T., Roccatello, D., Zignego, A. L., Pioltelli, P., Gabrielli, A., Filippini, D., Perrella, O., Migliaresi, S., Galli, M., Monti, G., Bombardieri, S.
Jazyk:	angličtina
Rok vydání:	2010
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______3659::01adebd4ad9590147de235f2d4a24db9 http://hdl.handle.net/11390/866460 Zobrazit plný text záznamu